Tumor microenvironment - TME

Biology of extracellular vesicles and the potential of tumor-derived vesicles for subverting immunotherapy of cancer
Theresa L Whiteside

Journal for ImmunoTherapy of Cancer Jan 2025, 13 (1) e010376; DOI: 10.1136/jitc-2024-010376
Stratification system with dual human endogenous retroviruses for predicting immunotherapy efficacy in metastatic clear-cell renal cell carcinoma
Xiaofan Lu, Yann-Alexandre Vano, Xiaoping Su, Virginie Verkarre, Cheng-Ming Sun, Wenxuan Cheng, Li Xu, Fangrong Yan, Salma Kotti, Wolf Hervé Fridman, Catherine Sautes-Fridman, Stéphane Oudard, Gabriel G. Malouf

Journal for ImmunoTherapy of Cancer Jan 2025, 13 (1) e010386; DOI: 10.1136/jitc-2024-010386
Selective expression and significance of ACKR2 in lung aerocytes
Francesca Albano, Valeria Mollica Poeta, Lucia Zotti, Alessandra Castagna, Arianna Felicetta, Alessandro Mesaglio, Elisa Zaghen, Marina Sironi, Arianna Capucetti, Rachele Di Donato, Mattia Laffranchi, Matteo Massara, Roberta Carriero, Gianluigi Condorelli, Silvano Sozzani, Alberto Mantovani, Massimo Locati, Raffaella Bonecchi

Journal for ImmunoTherapy of Cancer Jan 2025, 13 (1) e009467; DOI: 10.1136/jitc-2024-009467
Advances in the understanding and therapeutic manipulation of cancer immune responsiveness: a Society for Immunotherapy of Cancer (SITC) review
Alessandra Cesano, Ryan Augustin, Luigi Barrea, Davide Bedognetti, Tullia C Bruno, Alberto Carturan, Christian Hammer, Winson S Ho, Jakob Nikolas Kather, Tomas Kirchhoff, Rongze O Lu, Jennifer McQuade, Yana G Najjar, Violena Pietrobon, Marco Ruella, Rhine Shen, Laura Soldati, Christine Spencer, Allison Betof Warner, Sarah Warren, Elad Ziv, Francesco M Marincola

Journal for ImmunoTherapy of Cancer Jan 2025, 13 (1) e008876; DOI: 10.1136/jitc-2024-008876
Phase I study of BMS-986299, an NLRP3 agonist, as monotherapy and in combination with nivolumab and ipilimumab in patients with advanced solid tumors
Blessie E Nelson, Shaun O'Brien, Rahul A Sheth, David S Hong, Aung Naing, Xiaoping Zhang, Amy Xu, Lora Hamuro, Rasika Suryawanshi, Derrick McKinley, Ruslan D Novosiadly, Sarina A Piha-Paul

Journal for ImmunoTherapy of Cancer Jan 2025, 13 (1) e010013; DOI: 10.1136/jitc-2024-010013
MAF1 inhibits hepatocarcinogenesis by fostering an immunostimulatory tumor microenvironment
Di Cao, Yue-Ning Wang, Chao-Yue Sun, Haojiang Li, Ge Ren, Yu-Feng Zhou, Mei-Yin Zhang, Shuo-Cheng Wang, Shi-Juan Mai, Hui-Yun Wang

Journal for ImmunoTherapy of Cancer Jan 2025, 13 (1) e009656; DOI: 10.1136/jitc-2024-009656
Radiomics signature for dynamic monitoring of tumor inflamed microenvironment and immunotherapy response prediction
Kinga Bernatowicz, Ramon Amat, Olivia Prior, Joan Frigola, Marta Ligero, Francesco Grussu, Christina Zatse, Garazi Serna, Paolo Nuciforo, Rodrigo Toledo, Manel Escobar, Elena Garralda, Enriqueta Felip, Raquel Perez-Lopez

Journal for ImmunoTherapy of Cancer Jan 2025, 13 (1) e009140; DOI: 10.1136/jitc-2024-009140
Society for Immunotherapy of Cancer: updates and best practices for multiplex immunohistochemistry (IHC) and immunofluorescence (IF) image analysis and data sharing
Janis M Taube, Joel C Sunshine, Michael Angelo, Guray Akturk, Margaret Eminizer, Logan L Engle, Cláudia S Ferreira, Sacha Gnjatic, Benjamin Green, Shirley Greenbaum, Noah F Greenwald, Cyrus V Hedvat, Travis J Hollmann, Daniel Jiménez-Sánchez, Konstanty Korski, Ana Lako, Edwin R Parra, Marlon C Rebelatto, David L Rimm, Scott J Rodig, Jamie Rodriguez-Canales, Jeffrey S Roskes, Kurt A Schalper, Emanuel Schenck, Keith E Steele, Michael J Surace, Alexander S Szalay, Michael T Tetzlaff, Ignacio I Wistuba, Jennifer H Yearley, Carlo B Bifulco

Journal for ImmunoTherapy of Cancer Jan 2025, 13 (1) e008875; DOI: 10.1136/jitc-2024-008875
CREB3L1 facilitates pancreatic tumor progression and reprograms intratumoral tumor-associated macrophages to shape an immunotherapy-resistance microenvironment
Haiyan Xu, Shengbai Xue, Yang Sun, Jingyu Ma, Shumin Li, Yanling Wang, Tiebo Mao, Weiyu Ge, Ming Yue, Daiyuan Shentu, Wenxin Lu, Yongchao Wang, Jiong Hu, Jiujie Cui, Xiaofei Zhang, Li Cai, Yu Wang, Liwei Wang

Journal for ImmunoTherapy of Cancer Jan 2025, 13 (1) e010029; DOI: 10.1136/jitc-2024-010029
Lethal clinical outcome and chemotherapy and immunotherapy resistance in patients with urothelial carcinoma with MDM2 amplification or overexpression
Kaifeng Jin, Yawei Ding, Jingtong Xu, Zhaopei Liu, Han Zeng, Xiaohe Su, Lingkai Zhang, Jiaxing Sun, Yuzhen Wu, Hailong Liu, Yuan Chang, Yu Zhu, Zewei Wang, Le Xu, Weijuan Zhang, Jiejie Xu

Journal for ImmunoTherapy of Cancer Jan 2025, 13 (1) e010964; DOI: 10.1136/jitc-2024-010964

Main menu

Tumor microenvironment - TME

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

Tumor microenvironment - TME

Pages